Eisai
4523.T
#1919
Rank
HK$65.63 B
Marketcap
HK$232.84
Share price
-0.56%
Change (1 day)
-41.97%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : HK$25.43 Billion

According to Eisai's latest financial reports the company's total liabilities are HK$25.43 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31HK$25.97 B-13.43%
2022-03-31HK$30.00 B17.57%
2021-03-31HK$25.52 B-1.09%
2020-03-31HK$25.80 B-13.04%
2019-03-31HK$29.67 B-7.61%
2018-03-31HK$32.11 B7.9%
2017-03-31HK$29.76 B8.61%
2016-03-31HK$27.40 B-6.11%
2015-03-31HK$29.18 B-12.88%
2014-03-31HK$33.50 B-21.13%
2013-03-31HK$42.48 B-21.98%
2012-03-31HK$54.45 B-8.52%
2011-03-31HK$59.52 B5.42%
2010-03-31HK$56.46 B0.86%
2009-03-31HK$55.98 B7.19%
2008-03-31HK$52.22 B243.13%
2007-03-31HK$15.22 B1.31%
2006-03-31HK$15.02 B1.62%
2005-03-31HK$14.78 B0.75%
2004-03-31HK$14.67 B9.13%
2003-03-31HK$13.44 B23.33%
2002-03-31HK$10.90 B-13.01%
2001-03-31HK$12.53 B